Celyad Oncology SA (CYAD)
EU
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 138.81M | 77.63M | 94.3M | 89.84M | 66.08M | 79.94M | 19.72M | 16.28M |
Total Current Assets | 85.37M | 36.39M | 51.69M | 42.84M | 19.71M | 34.29M | 14.83M | 11.12M |
Cash and Equivalents | 48.36M | 23.25M | 40.54M | 39.34M | 17.23M | 30.02M | 12.45M | 7M |
Total Non-Current Assets | 90.89M | 47.54M | 55.59M | 45.62M | 30.99M | 43.64M | 4.32M | 6.3M |
Total Liabilities | 47.92M | 30.09M | 38.71M | 44.22M | 35.09M | 36.3M | 15.4M | 9.98M |
Total Current Liabilities | 11.28M | 7.95M | 9.65M | 11.92M | 11.83M | 13.83M | 10.43M | 2.93M |
Total Non-Current Liabilities | 37.56M | 22.95M | 29.95M | 35.3M | 25.78M | 24.21M | 5.09M | 7.95M |
Total Equity | 90.89M | 47.54M | 55.59M | 45.62M | 30.99M | 43.64M | 4.32M | 6.3M |
Common Equity | 32.57M | 34.34M | 41.55M | 48.51M | 48.51M | 78.59M | 78.59M | 32.95M |
Retained Earnings | -124.03M | -180.42M | -217.78M | -74.42M | -91.83M | -309M | -349.95M | -358.37M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.